Rite Aid

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through following segments: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Earnings data Q1 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Rite Aid is a drugstore chain that offers prescription medications, over-the-counter drugs, and health and wellness products. Rite Aid is reshaping the concept of a modern pharmacy by catering to customer demands through various convenient channels, including retail and delivery pharmacy services. Additionally, the company's offerings extend to services provided by its wholly-owned subsidiaries, namely Elixir, Bartell Drugs, and Health Dialog. Elixir, Rite Aid’s pharmacy benefits and services company, encompasses accredited mail and specialty pharmacies, prescription discount programs, and an advanced adjudication platform. These components combine to provide exceptional member experiences and substantial cost savings. Furthermore, Health Dialog delivers healthcare coaching and disease management services through interactive live online sessions and phone-based health services.

Rite Aid is a health products and services company with 2,400 locations across 17 states.

The company's omnichannel business includes digital, retail, and delivery touchpoints. Rite Aid is a top 20 seller of speciality medications, per its investor website.

In addition to its retail business, Rite Aid owns a pharmacy benefits subdivision (Elixir) and a personalized health services and coaching arm, Health Dialog, which has served 10MM members as of May 2022.

The company has reported $1.85 billion of liquidity with no debt maturities until 2025. According to its investor website, Rite Aid expects to be free cash flow (FCF) positive in FY23.

In Q2 2022, Rite Aid shared a three-part growth strategy aimed at deepening market share, expanding into new markets, and creating new offerings.

To grow the current business, Rite Aid is aiming to increase its e-commerce and digital sales, refresh its loyalty program, and grow its specialty pharmacy offering, which focuses on serving customers with complex health conditions.

New market expansion plans include increasing Rite Aid's footprint of "small format" pharmacies in underserved communities and implementing "store within a store" partnerships.

Rite Aid also aims to grow via new offerings, such as expanded health plan and health system clinical services, a pharmacy benefit manager (PBM) as a service offering, and new strategic partnerships.

Rite Aid Investor Relations

*This is not investment advice.

Did you lose money on investments in Rite Aid? If so, please visit Rite Aid Corporation Shareholder Class Action Lawsuit or contact  Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your rights.

RITE AID CORPORATION (NYSE: RAD) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Rite Aid Corporation (NYSE: RAD)

NEW YORK , March 24, 2023 /PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Rite Aid Corporation (NYSE:RAD) ("Rite Aid" or the "Company") and certain of its officers, on behalf of all persons and entities that purchased, or otherwise acquired Rite Aid securities between April 26, 2018 and March 13, 2023, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/rad.

Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Rite Aid Corporation (RAD) Investors of Class Action and to Actively Participate

Cyanotech

Better Choice Co

Veru

Vintage Wine Estates

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.

Top 5 Defensive Stocks That Are Set To Fly

PHILADELPHIA--(BUSINESS WIRE)--Rite Aid Corporation (NYSE: RAD) will release financial results for its Fiscal 2023 Fourth Quarter, which ended March 4, 2023, on Thursday, April 20, 2023. The company will hold an analyst call at 8:30 a.m. ET with remarks by Rite Aid's management team. The call will be broadcast at https://investors.riteaid.com. The telephone replay will be available beginning at 12:00 p.m. ET on Thursday, April 20, 2023, through 11:59 p.m. ET on May 21, 2023.

Rite Aid to Release Fourth Quarter Results on April 20

NEW YORK , March 22, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Rite Aid Corporation (NYSE: RAD) between April 26, 2018 and March 13, 2023, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.

EQUITY ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Rite Aid Corporation Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm - RAD

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Rite Aid Corporation (NYSE: RAD) between April 26, 2018 and March 13, 2023, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Rite Aid investors under the federal securities laws. To join the Rite Aid class action, go to https://rosenlegal.com/submit-form/?case_id=9388 or call Phillip Kim, Esq.

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Rite Aid Corporation Investors – RAD

Amazon

Amazon has apparently added another retailer to its stable of home-delivery partners. The eCommerce giant has teamed up with pharmacy chain Rite Aid to offer two-hour delivery to Amazon Prime members in parts of Newark, N.J.

Rite Aid Teams With Amazon to Offer 2-Hour Delivery

NEW YORK , March 15, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of Rite Aid Corporation (NYSE: RAD) resulting from allegations that Rite Aid may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Rite Aid securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

EQUITY ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Rite Aid Corporation Investors to Inquire About Securities Class Action Investigation - RAD

LOS ANGELES--(BUSINESS WIRE)---- $RAD #RAD--The Schall Law Firm Announces it is Investigating Claims Against Rite Aid Corporation and Encourages Investors with Losses to Contact the Firm

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Rite Aid Corporation and Encourages Investors with Losses to Contact the Firm

The U.S. Justice Department said Rite Aid “dispensed controlled substances in violation of the False Claims Act and the Controlled Substances Act.”

A Costly DOJ Probe Could Thwart Rite Aid Turn Around

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Rite Aid Corporation and Encourages Investors with Losses to Contact the Firm

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of Rite Aid Corporation (NYSE: RAD) resulting from allegations that Rite Aid may have issued materially misleading business information to the investing public.

EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Rite Aid Corporation Investors to Inquire About Securities Class Action Investigation – RAD

“These practices opened the floodgates for millions of opioid pills and other controlled substances to flow illegally out of Rite Aid's stores,” on DOJ official said.

US sues Rite Aid for repeated unlawful opioid prescriptions

The US government on Monday sued Rite Aid Corp, accusing the pharmacy chain of missing "red flags" as it illegally filled hundreds of thousands of prescriptions for controlled substances, including opioids.

US sues Rite Aid for missing opioid red flags

Drugstore chain Rite Aid Corp. fueled the nation's opioid crisis for several years by knowingly filling hundreds of thousands of illegal prescriptions for drugs like oxycodone and fentanyl, the U.S. alleged in a complaint announced Monday by the Justice Department.

U.S. alleges Rite Aid filled ‘hundreds of thousands' of unlawful prescriptions and ‘opened the floodgates' for illegal opioid market

Despite drab demand and supply-chain headwinds, Rite Aid's (RAD) online strength, led by expanded delivery services, increased non-COVID prescriptions and cost-saving initiatives, are likely to aid.

Rite Aid (RAD) Down 23.5% in Three Months: Can it Rebound?

American Eagle Outfitters

Blue Apron

Destination XL Group

Peloton

Wayfair

Party City Holdco Inc

These days, the U.S. economy isn't looking so hot. Inflation is still red-hot.

7 Retail Stocks to Skip as Shoppers Pull back on Spending

FuboTV

Heron Therapeutics

Stitch Fix

Short interest is high on these penny stocks. Time to buy or avoid them entirely?

Best Penny Stocks This Week? 4 Short Squeeze Stocks To Watch

Gossamer Bio Inc

Sana Biotechnology

Canoo

Are these penny stocks ready to squeeze? The post 4 Penny Stocks To Watch With High Short Interest In January 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

4 Penny Stocks To Watch With High Short Interest In January 2023

Rite Aid (RAD) reported earnings 30 days ago. What's next for the stock?

Why Is Rite Aid (RAD) Down 7% Since Last Earnings Report?

Carvana

Express

iMedia Brands

5 Retail Stocks to Put on Your 2023 Death Watch

Rite Aid Corporation is a name that is very familiar to arbitrageurs because of its history of failed mergers. Rite Aid recently announced that Heyward Donigan, the company's President and Chief Executive Officer, had stepped down, effective immediately.

C-Suite Transitions: Rite Aid CEO Departs Abruptly

Rite Aid (RAD) is reeling under elevated expenses. Yet, online strength, led by expanded delivery services, increased non-COVID prescriptions, and cost-saving initiatives, are likely to aid.

Can Rite Aid (RAD) Get Back on Track Via Solid Growth Efforts?

Rite Aid experienced a leadership shakeup as the pharmacy change announce CEO Heyward Donigan's exit and the appointment of an interim chief executive.

Rite Aid announces Heyward Donigan exit, appointment of interim CEO

Rite Aid has appointed an interim CEO as the company deals with a “dynamic environment.” Elizabeth “Busy” Burr, a member of the company's board of directors, takes on the role effective immediately and replaces Heyward Donigan, who has left the company after serving as president and CEO since August 2019, Rite Aid said in a Monday (Jan.

News for Rite Aid Stock (RAD)